NHS trusts in the south facing winter pressures
19th December 2024
As winter brings increased pressure to NHS Trusts in Bath, Salisbury, and Swindon, hospitals struggle with rising flu cases and strains on resources.
As winter brings increased pressure to NHS Trusts in Bath, Salisbury, and Swindon, hospitals struggle with rising flu cases and strains on resources.
One Health Group’s CMO, Mr. Shantanu Shahane, selected to represent UK at 76th Annual International Congress of the Egyptian Orthopaedic Association in Cairo.
Gynaecology care crisis on the rise in Bedfordshire, Luton, and Milton Keynes, as waiting lists for treatment soar nationwide, impacting patient well-being.
One Health Group plc (AQSE: OHGR), an independent provider of free, high quality NHS care for patients referred through ‘Patient Choice’ for treatment in orthopaedics, spine, general surgery and gynaecology, will
Discover how the UK healthcare system offers universal access with patient choice through the partnership between the NHS and providers like One Health Group.
Gynaecology waiting lists in the UK have more than doubled since early 2020, with current figures indicating over 755,000 pending appointments compared to 360,400 pre-pandemic. This backlog means at least
Recent figures highlight significant challenges for the NHS in England, with performance indicators falling short across emergency services and routine care. Emergency departments saw nearly 50,000 patients wait over 12
One Health Group plc (AQSE:OHGR) Chief Executive Officer Adam Binns caught up with DirectorsTalk for an exclusive interview to discuss factors shaping revenue growth, NHS tariff, planned surgical hub, market
NHS waiting lists have escalated significantly in the UK, leaving millions of patients facing extended delays for critical medical treatments. Funding shortfalls are a primary factor behind these delays. Despite
One Health Group (AQSE:OHGR) Chief Executive Officer Adam Binns joins DirectorsTalk to discuss a trading update for the six months to 30 September 2024. In this interview with Adam Binns, CEO
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
